I agree, Also, there may be an agreement with all involved (doctors/patients) to never discuss the company involved. I wonder if IPIX is even known to the participants/doctors? I'm sure there has to be patients that are curious if the treatment is a success? Long before interim or final results are announced... Get cured and buy shares along the way...
Seth Forman Clinical research consultant for protocol development, recruitment strategy and market analysis. Worked with AstraZeneca, AbbVie, Abbott, Celgene, CELLCEUTIX